This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gourmelen, A.
Right arrow Articles by Pernodet, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gourmelen, A.
Right arrow Articles by Pernodet, J.-L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 1998, p. 2612-2619, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Characterization of a Glycosyl Transferase Inactivating Macrolides, Encoded by gimA from Streptomyces ambofaciens

Anne Gourmelen, Marie-Hélène Blondelet-Rouault, and Jean-Luc Pernodet*

Institut de Génétique et Microbiologie, UMR 2225, Université Paris-Sud XI, Orsay, France

Received 11 March 1998/Returned for modification 15 May 1998/Accepted 4 August 1998

In Streptomyces ambofaciens, the producer of the macrolide antibiotic spiramycin, an open reading frame (ORF) was found downstream of srmA, a gene conferring resistance to spiramycin. The deduced product of this ORF had high degrees of similarity to Streptomyces lividans glycosyl transferase, which inactivates macrolides, and this ORF was called gimA. The cloned gimA gene was expressed in a susceptible host mutant of S. lividans devoid of any background macrolide-inactivating glycosyl transferase activity. In the presence of UDP-glucose, cell extracts from this strain could inactivate various macrolides by glycosylation. Spiramycin was not inactivated but forocidin, a spiramycin precursor, was modified. In vivo studies showed that gimA could confer low levels of resistance to some macrolides. The spectrum of this resistance differs from the one conferred by a rRNA monomethylase, such as SrmA. In S. ambofaciens, gimA was inactivated by gene replacement, without any deleterious effect on the survival of the strain, even under spiramycin-producing conditions. But the overexpression of gimA led to a marked decrease in spiramycin production. Studies with extracts from wild-type and gimA-null mutant strains revealed the existence of another macrolide-inactivating glycosyl transferase activity with a different substrate specificity. This activity might compensate for the effect of gimA inactivation.


* Corresponding author. Mailing address: Laboratoire de Biologie et Génétique Moléculaire, Institut de Génétique et Microbiologie, Bât. 400, Université Paris-Sud XI, 91405 Orsay Cedex, France. Phone: 33 (0) 1 69 15 69 13. Fax: 33 (0) 1 69 15 72 96. E-mail: pernodet{at}igmors.u-psud.fr.


Antimicrobial Agents and Chemotherapy, October 1998, p. 2612-2619, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dhote, V., Gupta, S., Reynolds, K. A. (2008). An O-Phosphotransferase Catalyzes Phosphorylation of Hygromycin A in the Antibiotic-Producing Organism Streptomyces hygroscopicus. Antimicrob. Agents Chemother. 52: 3580-3588 [Abstract] [Full Text]  
  • Karray, F., Darbon, E., Oestreicher, N., Dominguez, H., Tuphile, K., Gagnat, J., Blondelet-Rouault, M.-H., Gerbaud, C., Pernodet, J.-L. (2007). Organization of the biosynthetic gene cluster for the macrolide antibiotic spiramycin in Streptomyces ambofaciens. Microbiology 153: 4111-4122 [Abstract] [Full Text]  
  • Courtois, S., Cappellano, C. M., Ball, M., Francou, F.-X., Normand, P., Helynck, G., Martinez, A., Kolvek, S. J., Hopke, J., Osburne, M. S., August, P. R., Nalin, R., Guerineau, M., Jeannin, P., Simonet, P., Pernodet, J.-L. (2003). Recombinant Environmental Libraries Provide Access to Microbial Diversity for Drug Discovery from Natural Products. Appl. Environ. Microbiol. 69: 49-55 [Abstract] [Full Text]  
  • Bate, N., Butler, A. R., Smith, I. P., Cundliffe, E. (2000). The mycarose-biosynthetic genes of Streptomyces fradiae, producer of tylosin. Microbiology 146: 139-146 [Abstract] [Full Text]  
  • Pernodet, J.-L., Gourmelen, A., Blondelet-Rouault, M.-H., Cundliffe, E. (1999). Dispensable ribosomal resistance to spiramycin conferred by srmA in the spiramycin producer Streptomyces ambofaciens. Microbiology 145: 2355-2364 [Abstract] [Full Text]